- Strategy
- Payers
- AI
- Cybersecurity
- Device Development
- Studies/Published Research
- Ethics
- Regulatory
- Digital Biomarkers
- Data Science
- Companion Diagnostics
- Clinical Care
- Digital Therapeutics
- Academic Research
- Virtual Reality
- RWE
- Digital Endpoints
- Medical Devices (Class II and Class III)
- Commercialization
- Clinical Trials
- Drug-Device Combinations
- SaMD
- Remote Patient Monitoring
- Patient Engagement
- Profiles/Q&A
Verana Health, AAO Announce Research Network
IRIS Registry initiative to help advance data-driven clinical research and care.
Verana Health and the American Academy of Ophthalmology (Academy) announced the Verana Research Network, an IRIS Registry (Intelligent Research in Sight) initiative intended to help advance data-driven clinical research and care.
The network consists of academic medical centers (AMCs) and ophthalmology practices joining together to utilize IRIS Registry data and Verana Health capabilities to help improve patients' access to, and streamline healthcare providers' execution of clinical trials. The Verana Research Network includes 10 founding sites and is now inviting additional practices across the IRIS Registry to participate.
Verana Health is the Academy's exclusive end-to-end data curation and analytics partner for the IRIS Registry, established by the Academy in 2014.
As part of the Verana Research Network and an IRIS Registry benefit, practices can also opt-in to a program that allows clinical trial sponsors to see certain practices that may be a suitable site or referral practices for trials. This site selection capability will be available to sponsors in 2023.
Read more about the Verana Research Network.
